Sajad Karampoor
- Biological Psychiatry top 5%
- Cancer Research top 5%
- MicroRNA in disease regulation 14
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 13
- SARS-CoV-2 and COVID-19 Research 7
- Molecular Biology top 5%
- Gut microbiota and health 12
- Extracellular vesicles in disease 10
- Circular RNAs in diseases 10
-
- Multiple Sclerosis Research Studies 9
-
- Systemic Lupus Erythematosus Research 6
- Co-authors
- Rasoul MirzaeiRasoul YousefimashoufHossein KeyvaniSeyed Reza Hosseini‐FardSaba JalalifarAli TeimooriBehnaz BouzariFarhad Zamani
In The Last Decade
Sajad Karampoor
71 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Biological Psychiatry 131
- Applied Microbiology and Biotechnology 69
- Cancer Research 447
- Infectious Diseases 514
- Molecular Biology 1.3k
Countries citing papers authored by Sajad Karampoor
This map shows the geographic impact of Sajad Karampoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sajad Karampoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sajad Karampoor more than expected).
Fields of papers citing papers by Sajad Karampoor
This network shows the impact of papers produced by Sajad Karampoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sajad Karampoor. The network helps show where Sajad Karampoor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sajad Karampoor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 22 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 37 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 35 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 58 | |
| 13 | 2022 | 34 | |
| 14 | 2021 | 81 | |
| 15 | 2021 | 46 | |
| 16 | 2021 | 119 | |
| 17 | 2020 | 3 | |
| 18 | 2020 | 40 | |
| 19 | 2019 | 7 | |
| 20 | 2018 | 13 |
About Sajad Karampoor
Sajad Karampoor is a scholar working on Biological Psychiatry, Cancer Research and Infectious Diseases, having authored 72 papers that have together received 2.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (14 papers), COVID-19 Clinical Research Studies (13 papers), Gut microbiota and health (12 papers), Extracellular vesicles in disease (10 papers), Circular RNAs in diseases (10 papers), Multiple Sclerosis Research Studies (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Systemic Lupus Erythematosus Research (6 papers). The work is most often cited by research in Biological Psychiatry (131 citations), Applied Microbiology and Biotechnology (69 citations) and Cancer Research (447 citations). Sajad Karampoor has collaborated with scholars based in Iran, Iraq and Russia. Frequent co-authors include Rasoul Mirzaei, Rasoul Yousefimashouf, Hossein Keyvani, Seyed Reza Hosseini‐Fard, Saba Jalalifar, Ali Teimoori, Behnaz Bouzari, Farhad Zamani, Sima Kazemi and Yaghoub Ahmadyousefi. Their work appears in journals such as Frontiers in Microbiology, Journal of Cellular Physiology and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.